Bone Marrow Transplantation - Table of Contents alert Volume 48 Issue 12

TABLE OF CONTENTS Volume 48, Issue 12 (November 2013) In this issue Reviews Special Report Commentary Original Articles Letters to the Editor Erratum Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Read the most requested articles from Leukemia in 2013.  Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts   How to manage Waldenstrom's macroglobulinemia   Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety    Reviews Top Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era? L Chaudhary, M A Kharfan-Dabaja, P Hari and M Hamadani Bone Marrow Transplant 2013 48: 1489-1496; advance online publication, April 15, 2013; 10.1038/bmt.2013.56 Abstract | Full Text To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century C Ustun, H M Lazarus and D Weisdorf Bone Marrow Transplant 2013 48: 1497-1505; advance online publication, May 6, 2013; 10.1038/bmt.2013.67 Abstract | Full Text Special Report Top Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation B E Shaw, J Chapman, M Fechter, L Foeken, H Greinix, W Hwang, L Phillips-Johnson, M Korhonen, B Lindberg, W H Navarro and J Szer Bone Marrow Transplant 2013 48: 1506-1509; advance online publication, July 29, 2013; 10.1038/bmt.2013.104 Abstract | Full Text Commentary Top Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice B E Shaw, J Robinson, K Fleischhauer, J A Madrigal and S G E Marsh Bone Marrow Transplant 2013 48: 1510-1512; advance online publication, July 1, 2013; 10.1038/bmt.2013.91 Full Text Original Articles Top CONDITIONING REGIMENS Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation H Kanamori, S Mizuta, S Kako, H Kato, S Nishiwaki, K Imai, A Shigematsu, H Nakamae, M Tanaka, K Ikegame, T Yujiri, T Fukuda, K Minagawa, T Eto, T Nagamura-Inoue, Y Morishima, R Suzuki, H Sakamaki and J Tanaka Bone Marrow Transplant 2013 48: 1513-1518; advance online publication, September 23, 2013; 10.1038/bmt.2013.140 Abstract | Full Text PEDIATRIC TRANSPLANTS Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemia D-H Liu, L-P Xu, K-Y Liu, Y Wang, H Chen, W Han, X-H Zhang, C-H Yan, Y-Y Zhang, J-Z Wang, Y-H Chen, F-R Wang and X-J Huang Bone Marrow Transplant 2013 48: 1519-1524; advance online publication, July 29, 2013; 10.1038/bmt.2013.99 Abstract | Full Text ALLOGRAFTING The impact of morphological and immunohistological changes in minor salivary glands on the health of the oral cavity in HSCT patients T C B Soares, M E P Correa, G F Cintra, E C M Miranda and M L Cintra Bone Marrow Transplant 2013 48: 1525-1529; advance online publication, July 29, 2013; 10.1038/bmt.2013.105 Abstract | Full Text AUTOGRAFTING Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin’s lymphoma: outcome after high-dose chemotherapy and auto-SCT S Akhtar, A S Al-Sugair, M Abouzied, Y AlKadhi, M Dingle, M Abdelsalam, H Soudy, A Darwish, A Eltigani, T A M Elhassan, M Nabil-Ahmed and I Maghfoor Bone Marrow Transplant 2013 48: 1530-1536; advance online publication, June 10, 2013; 10.1038/bmt.2013.88 Abstract | Full Text Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115 V Sanchorawala, A Hoering, D C Seldin, K T Finn, S A Fennessey, R Sexton, B Mattar, H F Safah, L A Holmberg, R M Dean, R Z Orlowski and B Barlogie Bone Marrow Transplant 2013 48: 1537-1542; advance online publication, July 15, 2013; 10.1038/bmt.2013.98 Abstract | Full Text Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT S V Glavey, M A Gertz, A Dispenzieri, S Kumar, F Buadi, M Lacy, S R Hayman, D Dingli, A McCurdy, W J Hogan, D A Gastineau and N Leung Bone Marrow Transplant 2013 48: 1543-1547; advance online publication, August 5, 2013; 10.1038/bmt.2013.109 Abstract | Full Text MICROBIAL ISSUES Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit OPEN N Lehners, P Schnitzler, S Geis, J Puthenparambil, M A Benz, B Alber, T Luft, P Dreger, C Eisenbach, C Kunz, A Benner, U Buchholz, E Aichinger, U Frank, K Heeg, A D Ho and G Egerer Bone Marrow Transplant 2013 48: 1548-1553; advance online publication, July 1, 2013; 10.1038/bmt.2013.94 Abstract | Full Text Outcomes of hematopoietic SCT recipients with rhinovirus infection: a matched, case–control study F I Abandeh, M Lustberg, S Devine, P Elder, L Andritsos and S I Martin Bone Marrow Transplant 2013 48: 1554-1557; advance online publication, July 22, 2013; 10.1038/bmt.2013.100 Abstract | Full Text Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation J Casey, K Morris, M Narayana, M Nakagaki and G A Kennedy Bone Marrow Transplant 2013 48: 1558-1561; advance online publication, August 5, 2013; 10.1038/bmt.2013.112 Abstract | Full Text POST-TRANSPLANT EVENTS Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA? J-H Yoon, W-S Min, H-Je Kim, J-H Kim, S-H Shin, S-A Yahng, S-E Lee, B-S Cho, K-S Eom, Y-J Kim, S Lee, C-K Min, S-G Cho, D-W Kim, J-W Lee and C-W Park Bone Marrow Transplant 2013 48: 1562-1568; advance online publication, July 29, 2013; 10.1038/bmt.2013.101 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Active thrombopoiesis is associated with worse severity and activity of chronic GVHD T Bat, S M Steinberg, R Childs, K R Calvo, A J Barrett, M Battiwalla, K Baird, D Zhang, D Pulanic, C E Dunbar and S Z Pavletic Bone Marrow Transplant 2013 48: 1569-1573; advance online publication, July 8, 2013; 10.1038/bmt.2013.95 Abstract | Full Text Nailfold capillary abnormalities in sclerodermatous chronic GVHD H M A Hofstee, T T de Waal, S Zweegman, A E Voskuyl, Y M Smulders, M C E Schoordijk, J J W M Janssen and E H Serné Bone Marrow Transplant 2013 48: 1574-1577; advance online publication, July 29, 2013; 10.1038/bmt.2013.106 Abstract | Full Text Letters to the Editor Top Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation B K Hamilton, B Bolwell, M Kalaycio, L Rybicki, R Hanna, R Sobecks, B Pohlman, S Andresen, R Dean, H Duong, B Hill and E Copelan Bone Marrow Transplant 2013 48: 1578-1580; advance online publication, June 10, 2013; 10.1038/bmt.2013.89 Full Text ‘Yet another rose’ R P Gale and H M Lazarus Bone Marrow Transplant 2013 48: 1581; advance online publication, June 17, 2013; 10.1038/bmt.2013.92 Full Text In situ chimerism after double cord blood transplantation H Labussière, P Loiseau, E Clave, A Janin and G Socié Bone Marrow Transplant 2013 48: 1582; advance online publication, July 22, 2013; 10.1038/bmt.2013.102 Full Text Pre-engraftment blood stream infection is a risk factor for acute GVHD grades II–IV O Blennow, J Mattsson and M Remberger Bone Marrow Transplant 2013 48: 1583-1584; advance online publication, July 22, 2013; 10.1038/bmt.2013.103 Full Text Successful management of Candida krusei monoarthritis after allo-SCT K Mayer, M Kapelle, A Kaeferstein, M Weßling, I Bekeredjian-Ding, C Leutner, M von Lilienfeld-Toal, P Brossart and D Wolf Bone Marrow Transplant 2013 48: 1585-1586; advance online publication, July 29, 2013; 10.1038/bmt.2013.108 Full Text Erratum Top Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation H Kanamori, S Mizuta, S Kako, H Kato, S Nishiwaki, K Imai, A Shigematsu, H Nakamae, M Tanaka, K Ikegame, T Yujiri, T Fukuda, K Minagawa, T Eto, T Nagamura-Inoue, Y Morishima, R Suzuki, H Sakamaki and J Tanaka Bone Marrow Transplant 2013 48: 1587; 10.1038/bmt.2013.179 Full Text Corrigendum Top In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study C Aristei, A Santucci, R Corvò, G Gardani, U Ricardi, G Scarzello, S M Magrini, V Donato, L Falcinelli, A Bacigalupo, F Locatelli, F Aversa and E Barbieri and Italian TBI working group Bone Marrow Transplant 2013 48: 1588; 10.1038/bmt.2013.183 Full Text Advertisement Cell Research Editor's Choice 2013 Cell Research is proud to present the Editor's Choice 2013 - a collection of featured articles from 2013 that represent articles from across basic molecular and cell biology research. Featuring content related to: -Stem cell research -Aging -Structural biology -Viral infections -Genome editing -Cell signaling Take advantage of free access to select articles from the Editor's Choice 2013 collection today!    Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.